Both in Biotechnology
Neumora Therapeutics vs enGene Therapeutics
Over the past year NMRA returned −61.5% and ENGN returned −69.8%; their daily moves had a correlation of 0.14.
NMRA −61.5% ENGN −69.8%Growth of $1, one year, split-adjusted
| Metric | NMRA | ENGN |
|---|---|---|
| Price | $0.6776 | $1.95 |
| Market cap | $127.3M | $130.7M |
| Today | −2.05% | −1.02% |
| 1 month | −51.3% | +6.8% |
| 6 months | −64.9% | −68.4% |
| Year to date | −62.1% | −78.4% |
| 1 year | −61.1% | −70.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $63.9M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 78.4% | 45.3% |
| Short % of float | 8.5% | 2.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).